Literature DB >> 25278708

Identification of pathologic features associated with "ulcerative colitis-like" Crohn's disease.

Samuel D James1, Paul E Wise1, Tania Zuluaga-Toro1, David A Schwartz1, M Kay Washington1, Chanjuan Shi1.   

Abstract

AIM: To identify pathologic features associated with this "ulcerative colitis (UC)-like" subgroup of Crohn's disease (CD).
METHODS: Seventeen subjects diagnosed as having UC who underwent proctocolectomy (RPC) from 2003-2007 and subsequently developed CD of the ileal pouch were identified. UC was diagnosed based on pre-operative clinical, endoscopic, and pathologic studies. Eighteen patients who underwent RPC for UC within the same time period without subsequently developing CD were randomly selected and used as controls. Pathology reports and histological slides were reviewed for a wide range of gross and microscopic pathological features, as well as extent of disease. The demographics, gross description and histopathology of the resection specimens were reviewed and compared between the two groups.
RESULTS: Patients with "UC-like" CD were on average 13 years younger than those with "true" UC (P < 0.01). More severe disease in the proximal involved region and active ileitis with/without architectural distortion were observed in 6 of 17 (35%) and 7 of 17 (41%) "UC-like" CD cases, respectively, but in none of the "true" UC cases (P < 0.05). Active appendicitis occurred in 8 of 16 (50%) "UC-like" CD cases but in only two (11%) "true" UC cases (P < 0.05). Conspicuous lamina propria neutrophils were more specific for "UC-like" CD (76% vs 22%, P < 0.05). In addition, prominent lymphoid aggregates tended to be more common in "UC-like" CD (P = 0.07). The "true" UC group contained a greater number of cases with severe activity (78% vs 47%). Therefore, the features more commonly seen in "UC-like" CD were not due to a more severe disease process. Crohn's granulomas and transmural inflammation in non-ulcerated areas were absent in both groups.
CONCLUSION: More severe disease in the proximal involved region, terminal ileum involvement, active appendicitis, and prominent lamina propria neutrophils may be morphological factors associated with "UC-like" CD.

Entities:  

Keywords:  Crohn’s colitis; Inflammatory bowel disease; Ulcerative colitis; Ulcerative colitis-like Crohn’s disease

Mesh:

Year:  2014        PMID: 25278708      PMCID: PMC4177493          DOI: 10.3748/wjg.v20.i36.13139

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure.

Authors:  Carl J Brown; Anthony R Maclean; Zane Cohen; Helen M Macrae; Brenda I O'Connor; Robin S McLeod
Journal:  Dis Colon Rectum       Date:  2005-08       Impact factor: 4.585

2.  Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients.

Authors:  A Lapidus; O Bernell; G Hellers; R Löfberg
Journal:  Gastroenterology       Date:  1998-06       Impact factor: 22.682

3.  Incidence of Crohn's disease in Stockholm County 1955-1989.

Authors:  A Lapidus; O Bernell; G Hellers; P G Persson; R Löfberg
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

4.  Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis.

Authors:  Henry Haskell; Charles W Andrews; Sarathchandra I Reddy; Klea Dendrinos; Francis A Farraye; Arthur F Stucchi; James M Becker; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2005-11       Impact factor: 6.394

5.  Analysis of the outcome of ileal pouch-anal anastomosis in patients with Crohn's disease.

Authors:  J E Hartley; V W Fazio; F H Remzi; I C Lavery; J M Church; S A Strong; T L Hull; A J Senagore; C P Delaney
Journal:  Dis Colon Rectum       Date:  2004-11       Impact factor: 4.585

6.  Morphology of colorectal lymphoid aggregates in cancer, diverticular and inflammatory bowel diseases.

Authors:  Riccardo Nascimbeni; Francesco Di Fabio; Ernesto Di Betta; Pierpaolo Mariani; Simona Fisogni; Vincenzo Villanacci
Journal:  Mod Pathol       Date:  2005-05       Impact factor: 7.842

7.  Ulcerative appendicitis in universal and nonuniversal ulcerative colitis.

Authors:  G M Groisman; J George; N Harpaz
Journal:  Mod Pathol       Date:  1994-04       Impact factor: 7.842

8.  Appendiceal inflammation in ulcerative colitis.

Authors:  I S Scott; M Sheaff; A Coumbe; R M Feakins; D S Rampton
Journal:  Histopathology       Date:  1998-08       Impact factor: 5.087

9.  Rediversion after ileal pouch-anal anastomosis. Causes of failures and predictors of subsequent pouch salvage.

Authors:  E F Foley; D J Schoetz; P L Roberts; P W Marcello; J J Murray; J A Coller; M C Veidenheimer
Journal:  Dis Colon Rectum       Date:  1995-08       Impact factor: 4.585

10.  The fate of the ileal pouch in patients developing Crohn's disease.

Authors:  Joshua M Braveman; David J Schoetz; Peter W Marcello; Patricia L Roberts; John A Coller; John J Murray; Lawrence C Rusin
Journal:  Dis Colon Rectum       Date:  2004-10       Impact factor: 4.585

View more
  8 in total

1.  Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis.

Authors:  Ondrej Fabian; Ondrej Hradsky; Tereza Drskova; Filip Mikus; Josef Zamecnik; Jiri Bronsky
Journal:  Dig Dis Sci       Date:  2018-03-14       Impact factor: 3.199

2.  Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study.

Authors:  Travis J Meyers; Adam B Weiner; Rebecca E Graff; Anuj S Desai; Lauren Folgosa Cooley; William J Catalona; Stephen B Hanauer; Jennifer D Wu; Edward M Schaeffer; Sarki A Abdulkadir; Shilajit D Kundu; John S Witte
Journal:  Int J Cancer       Date:  2020-05-29       Impact factor: 7.396

Review 3.  Histopathology of IBD Colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD).

Authors:  Vincenzo Villanacci; Luca Reggiani-Bonetti; Tiziana Salviato; Giuseppe Leoncini; Moris Cadei; Luca Albarello; Alessandro Caputo; Maria Costanza Aquilano; Serena Battista; Paola Parente
Journal:  Pathologica       Date:  2021-02

4.  Multiple Enteroenteric Fistulas- Crohn's Disease- A Case Report.

Authors:  Hasnain Abbas Dharamshi; Ali Abbas Mohsin Ali; Tufail Raza; Narmeen Shahid; Faizan Sheraz; Tooba Sajid; Zohair Lilani; Mustaqueem Ur Rehman; Taha Nafees
Journal:  Iran J Public Health       Date:  2015-11       Impact factor: 1.429

5.  Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.

Authors:  Amanda D Williams; Olga Y Korolkova; Amos M Sakwe; Timothy M Geiger; Samuel D James; Roberta L Muldoon; Alan J Herline; J Shawn Goodwin; Michael G Izban; Mary K Washington; Duane T Smoot; Billy R Ballard; Maria Gazouli; Amosy E M'Koma
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

6.  Analysis and Follow up of Endoscopy Results in 1099 Patients with Terminal Ileum Lesions.

Authors:  Qinglian Zhong; Anye Zhang; Jian Huang; Wen Yan; Jiayu Lin; Qun Huang; Xiaoshan Huang; Tao Yu; Luhong Zhu; Chen Xu
Journal:  Can J Gastroenterol Hepatol       Date:  2020-12-04

Review 7.  Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.

Authors:  Chiara Rocchi; Youssef Y Soliman; Marco Massidda; Salvatore F Vadalà di Prampero; Milutin Bulajic; Dario Sorrentino
Journal:  Dig Dis Sci       Date:  2021-06-07       Impact factor: 3.487

8.  Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease.

Authors:  Tanu Rana; Olga Y Korolkova; Girish Rachakonda; Amanda D Williams; Alexander T Hawkins; Samuel D James; Amos M Sakwe; Nian Hui; Li Wang; Chang Yu; Jeffrey S Goodwin; Michael G Izban; Regina S Offodile; Mary K Washington; Billy R Ballard; Duane T Smoot; Xuan-Zheng Shi; Digna S Forbes; Anil Shanker; Amosy E M'Koma
Journal:  PLoS One       Date:  2021-03-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.